Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Arcellx, Inc. ACLX |
BLACKROCK INC BLK |
3,527,220 6.400% |
-719,472 (-16.94%) |
Filing History |
| 2025-02-27 4:23 pm Purchase |
2025-02-27 | 13D | Arcellx, Inc. ACLX |
Rami Elghandour | 3,997,132 6.900% |
1,146,467 (+40.22%) |
Filing History |
| 2025-02-12 09:16 am Purchase |
2024-12-31 | 13G | Arcellx, Inc. ACLX |
FMR CORP | 7,956,633 14.700% |
1,477,360 (+22.80%) |
Filing History |
| 2025-01-30 9:34 pm Purchase |
2024-12-31 | 13G | Arcellx, Inc. ACLX |
The Vanguard Group | 3,330,092 6.150% |
3,330,092 (New Position) |
Filing History |
| 2024-11-22 4:12 pm Purchase |
2024-11-15 | 13G | Arcellx, Inc. ACLX |
RA Capital Management, L.P. | 2,787,327 5.200% |
2,787,327 (New Position) |
Filing History |
| 2024-11-14 4:35 pm Purchase |
2024-09-30 | 13G | Arcellx, Inc. ACLX |
Paradigm BioCapital Advisors LP | 4,800,000 8.900% |
1,141,376 (+31.20%) |
Filing History |
| 2024-11-14 4:31 pm Sale |
2024-09-30 | 13G | Arcellx, Inc. ACLX |
PERCEPTIVE ADVISORS LLC | 3,888,669 7.200% |
-656,140 (-14.44%) |
Filing History |
| 2024-11-12 09:50 am Purchase |
2024-11-08 | 13G | Arcellx, Inc. ACLX |
FMR CORP | 6,479,273 12.053% |
1,084,778 (+20.11%) |
Filing History |
| 2024-11-08 4:40 pm Purchase |
2024-11-03 | 13D | Arcellx, Inc. ACLX |
Rami Elghandour | 2,850,665 5.000% |
2,850,665 (New Position) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Arcellx, Inc. ACLX |
BLACKROCK INC BLK |
4,246,692 7.900% |
0 (Unchanged) |
Filing History |
| 2024-10-22 3:24 pm Purchase |
2024-09-30 | 13G | Arcellx, Inc. ACLX |
BLACKROCK INC BLK |
4,246,692 7.900% |
1,228,154 (+40.69%) |
Filing History |
| 2024-04-10 10:06 am Purchase |
2024-04-09 | 13G | Arcellx, Inc. ACLX |
FMR CORP | 5,394,495 10.217% |
1,015,326 (+23.19%) |
Filing History |
| 2024-03-25 6:41 pm Sale |
2024-03-21 | 13D | Arcellx, Inc. ACLX |
SR ONE CAPITAL MANAGEMENT LLC | 2,346,630 4.440% |
-800,000 (-25.42%) |
Filing History |
| 2024-02-14 5:57 pm Purchase |
2023-12-31 | 13G | Arcellx, Inc. ACLX |
Paradigm BioCapital Advisors LP | 3,658,624 7.000% |
1,235,924 (+51.01%) |
Filing History |
| 2024-02-14 4:48 pm Purchase |
2023-12-31 | 13G | Arcellx, Inc. ACLX |
PERCEPTIVE ADVISORS LLC | 4,544,809 8.800% |
1,946,504 (+74.91%) |
Filing History |
| 2024-02-13 11:50 am Purchase |
2023-12-31 | 13G | Arcellx, Inc. ACLX |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,435,974 5.000% |
85,641 (+3.64%) |
Filing History |
| 2024-02-09 08:35 am Purchase |
2024-02-08 | 13G | Arcellx, Inc. ACLX |
FMR CORP | 4,379,169 8.994% |
4,379,169 (New Position) |
Filing History |
| 2024-01-29 3:26 pm Purchase |
2023-12-31 | 13G | Arcellx, Inc. ACLX |
BLACKROCK INC BLK |
3,018,538 6.200% |
862,389 (+40.00%) |
Filing History |
| 2023-12-28 5:06 pm Purchase |
2023-12-28 | 13G | Arcellx, Inc. ACLX |
GILEAD SCIENCES INC GILD |
6,720,803 12.900% |
3,242,542 (+93.22%) |
Filing History |
| 2023-12-18 4:16 pm Sale |
2023-12-14 | 13D | Arcellx, Inc. ACLX |
SR ONE CAPITAL MANAGEMENT LLC | 3,146,630 6.460% |
-800,000 (-20.27%) |
Filing History |